A Nadofaragene firadenovec 3boxes,Ｂ Tagraxofusp (genetical recombination) 10vials,Ｃ onasemnogene abeparvovec-brve 1vial

⑴ Official in charge of disbursement of the procuring entity : Yasuto Tachikawa, President, Kyoto University ⑵ Classification of the products to be procured : 4 ⑶ Nature and quantity of the products to be purchased : A Nadofaragene firadenovec 3boxes B Tagraxofusp (genetical recombination) 10vials C onasemnogene abeparvovec-brve 1vial ⑷ Delivery period : From 7 December, 2026 through 31 March, 2028 ⑸ Delivery place : Kyoto University Hospital ⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A not come under Article 4 of the Regulation concerning the Contract for Kyoto University, B have the Grade A, Grade B or Grade C qualification during fiscal 2026 in the Kinki area in sales of product for participating in tenders by Single qualification for every ministry and agency, C meet content specified in the tender documentation, D prove to have obtained the first-class license for selling drugs in accordance with the Pharmaceutical and Medical Device Act, E prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by President, F not be currently under a suspension of business order as instructed by Kyoto University. ⑺ Time limit of tender : 12 : 00 2 December, 2026 ⑻ Contact point for the notice : Yosuke Tamura Procurement Section, Accounting Division, Kyoto University Hospital 54 Kawahara-cho Shogoin Sakyo-ku Kyoto-shi 606-8507 Japan TEL 075-751-3266 ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents. 0004 Medical & Pharmaceutical Products